Teixeira FV, Parra RS, Feres O, Kotze PG. Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?. Clinics. 2019;74:e1424. doi:10.6061/clinics/2019/e1424